- Home
- GKOS vs TLN Comparison
GKOS vs TLN Comparison
Compare GKOS & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GKOS
- TLN
- Stock Information
- Founded
- GKOS 1998
- TLN 2015
- Country
- GKOS United States
- TLN United States
- Employees
- GKOS N/A
- TLN N/A
- Industry
- GKOS Medical/Dental Instruments
- TLN Electric Utilities: Central
- Sector
- GKOS Health Care
- TLN Utilities
- Exchange
- GKOS Nasdaq
- TLN Nasdaq
- Market Cap
- GKOS 8.4B
- TLN 8.1B
- IPO Year
- GKOS 2015
- TLN N/A
- Fundamental
- Price
- GKOS $102.04
- TLN $197.48
- Analyst Decision
- GKOS Strong Buy
- TLN Strong Buy
- Analyst Count
- GKOS 13
- TLN 11
- Target Price
- GKOS $161.54
- TLN $242.27
- AVG Volume (30 Days)
- GKOS 1.0M
- TLN 1.5M
- Earning Date
- GKOS 04-30-2025
- TLN 02-27-2025
- Dividend Yield
- GKOS N/A
- TLN N/A
- EPS Growth
- GKOS N/A
- TLN 681.86
- EPS
- GKOS N/A
- TLN 17.67
- Revenue
- GKOS $383,481,000.00
- TLN $2,073,000,000.00
- Revenue This Year
- GKOS $27.84
- TLN $9.02
- Revenue Next Year
- GKOS $27.99
- TLN $20.04
- P/E Ratio
- GKOS N/A
- TLN $11.18
- Revenue Growth
- GKOS 21.85
- TLN N/A
- 52 Week Low
- GKOS $88.16
- TLN $90.89
- 52 Week High
- GKOS $163.71
- TLN $258.03
- Technical
- Relative Strength Index (RSI)
- GKOS 37.88
- TLN 44.41
- Support Level
- GKOS $98.03
- TLN $198.18
- Resistance Level
- GKOS $108.62
- TLN $220.59
- Average True Range (ATR)
- GKOS 3.96
- TLN 10.55
- MACD
- GKOS 1.87
- TLN 1.17
- Stochastic Oscillator
- GKOS 47.86
- TLN 59.58
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
About TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.